{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T11:30:53Z","timestamp":1775129453433,"version":"3.50.1"},"reference-count":11,"publisher":"BMJ","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/bmj.com\/coronavirus\/usage"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2021,9,15]]},"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:p>SARS-COV-2 predominantly results in a respiratory illness. However, it has also been associated with a wide range of neurological disorders including a broad range of immune neuropathies. These immune neuropathies associated with SARS-COV2 infection include Guillain-Barr\u00e9 syndrome (GBS), recurrent GBS and exacerbation of pre-existing chronic inflammatory demyelinating polyneuropathy (CIDP). We describe a case with acute-onset CIDP presenting with three relapses of demyelinating polyradiculoneuropathy, the third relapse occurring in the 8\u2009week of illness following a previous COVID-19 infection and a recent COVID-19 vaccination with ChAdOx1 nCoV-19 and high COVID-19 antibody level. In our knowledge, this is the ever reported case of acute-onset CIDP associated with COVID-19 vaccine and high COVID-19 antibody level.<\/jats:p>","DOI":"10.1136\/bcr-2021-245816","type":"journal-article","created":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T13:03:34Z","timestamp":1633352614000},"page":"e245816","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":34,"title":["Acute-onset chronic inflammatory demyelinating polyneuropathy after COVID-19 infection and subsequent ChAdOx1 nCoV-19 vaccination"],"prefix":"10.1136","volume":"14","author":[{"given":"Vinit","family":"Suri","sequence":"first","affiliation":[{"name":"Neurology, Indraprastha Apollo Hospital, New Delhi, Delhi, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shishir","family":"Pandey","sequence":"additional","affiliation":[{"name":"Neurology, Indraprastha Apollo Hospital, New Delhi, Delhi, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyoti","family":"Singh","sequence":"additional","affiliation":[{"name":"Neurology, Indraprastha Apollo Hospital, New Delhi, Delhi, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amarnath","family":"Jena","sequence":"additional","affiliation":[{"name":"Nuclear Medicine, Indraprastha Apollo Hospital, New Delhi, Delhi, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,10,4]]},"reference":[{"key":"2025082701565260000_14.10.e245816.1","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s00415-020-10124-x","article-title":"Guillain-Barr\u00e9 syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases","volume":"268","author":"Abu-Rumeileh","year":"2021","journal-title":"J Neurol"},{"key":"2025082701565260000_14.10.e245816.2","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens9110965","article-title":"COVID-19 as a trigger of recurrent Guillain\u2013Barr\u00e9 syndrome","volume":"9","author":"McDonnell","year":"2020","journal-title":"Pathogens"},{"key":"2025082701565260000_14.10.e245816.3","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1007\/s00415-021-10417-9","article-title":"COVID-19-induced exacerbation of chronic inflammatory demyelinating polyneuropathy","volume":"268","author":"Van Looy","year":"2021","journal-title":"J Neurol"},{"key":"2025082701565260000_14.10.e245816.4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.117106","article-title":"Exacerbation of chronic inflammatory demyelinating polyneuropathy in concomitance with COVID-19","volume":"418","author":"Abu-Rumeileh","year":"2020","journal-title":"J Neurol Sci"},{"key":"2025082701565260000_14.10.e245816.5","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-52001-2.00007-8"},{"key":"2025082701565260000_14.10.e245816.6","doi-asserted-by":"publisher","DOI":"10.1159\/000052111"},{"key":"2025082701565260000_14.10.e245816.7","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2008.156463"},{"key":"2025082701565260000_14.10.e245816.8","doi-asserted-by":"publisher","DOI":"10.1159\/000052111"},{"key":"2025082701565260000_14.10.e245816.9","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000167549.09664.b8"},{"key":"2025082701565260000_14.10.e245816.10","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30109-5"},{"key":"2025082701565260000_14.10.e245816.11","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/jns.12266","article-title":"Differences between acute-onset chronic inflammatory demyelinating polyneuropathy and acute inflammatory demyelinating polyneuropathy in adult patients","volume":"23","author":"Alessandro","year":"2018","journal-title":"J Peripher Nerv Syst"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2021-245816","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T08:57:01Z","timestamp":1756285021000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2021-245816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":11,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10,4]]},"published-print":{"date-parts":[[2021,10]]}},"alternative-id":["10.1136\/bcr-2021-245816"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2021-245816","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10]]}}}